Cargando…

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery

OBJECTIVE: The reported association between calibrated integrated backscatter (cIB) and myocardial fibrosis is based on study of patients with dilated or hypertrophic cardiomyopathy and extensive (mean 15–34%) fibrosis. Its association with lesser degrees of fibrosis is unknown. We examined the rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prior, David L, Somaratne, Jithendra B, Jenkins, Alicia J, Yii, Michael, Newcomb, Andrew E, Schalkwijk, Casper G, Black, Mary J, Kelly, Darren J, Campbell, Duncan J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555070/ https://www.ncbi.nlm.nih.gov/pubmed/26339497 http://dx.doi.org/10.1136/openhrt-2015-000278

Ejemplares similares

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Complications and prognosis of patients undergoing apical or septal right ventricular pacing
por: Spath, Nick B, et al.
Publicado: (2019)

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease
por: Liu, Dan, et al.
Publicado: (2018)

Demographic features and prevalence of myocarditis in patients undergoing transarterial endomyocardial biopsy for unexplained cardiomyopathy
por: Hassan, Ayman K.M., et al.
Publicado: (2017)

Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure
por: Sato, Yu, et al.
Publicado: (2017)

CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis
por: Chevalier, Céleste, et al.
Publicado: (2022)

Prognostic importance of the Controlling Nutritional Status (CONUT) score in patients undergoing cardiac resynchronisation therapy
por: Ikeya, Yukitoshi, et al.
Publicado: (2021)

Habitual physical activity levels of adults with heart failure: systematic review and meta-analysis
por: Jordan, Cara, et al.
Publicado: (2023)

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2015)

Diagnostic accuracy of handheld cardiac ultrasound device for assessment of left ventricular structure and function: systematic review and meta-analysis
por: Jenkins, Sam, et al.
Publicado: (2021)

Smoking intensity and duration is associated with cardiac structure and function: the ECHOcardiographic Study of Hispanics/Latinos
por: Leigh, J Adam, et al.
Publicado: (2017)

Stress-coping skills and neuroticism in apical ballooning syndrome (Takotsubo/stress cardiomyopathy)
por: Scantlebury, Dawn C, et al.
Publicado: (2016)

Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates
por: Janoušek, J, et al.
Publicado: (2009)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy
por: Warriner, David R, et al.
Publicado: (2016)

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
por: Medenwald, D, et al.
Publicado: (2014)

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
por: Woods, B, et al.
Publicado: (2015)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study
por: Beattie, James M, et al.
Publicado: (2020)

CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19
por: Ilonze, Onyedika J., et al.
Publicado: (2021)

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
por: Cannon, Jane A, et al.
Publicado: (2015)

Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies
por: Wang, Mary, et al.
Publicado: (2018)

Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy
por: Cherubin, Sinaida, et al.
Publicado: (2020)

A Score to differentiate Takotsubo syndrome from non-ST-elevation myocardial nfarction in women at the bedside
por: Looi, Jen-Li, et al.
Publicado: (2020)

Higher number of live births is associated with left ventricular diastolic dysfunction and adverse cardiac remodelling among US Hispanic/Latina women: results from the Echocardiographic Study of Latinos
por: Aggarwal, Shivani R, et al.
Publicado: (2017)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
por: Law, Steven, et al.
Publicado: (2022)

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature
por: Captur, Gabriella, et al.
Publicado: (2018)

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
por: McAloon, Christopher J, et al.
Publicado: (2017)

Update in imaging of cancer therapy-related cardiac toxicity in adults
por: de Baat, Esmée C, et al.
Publicado: (2021)

Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction
por: Mentz, Robert J, et al.
Publicado: (2015)

Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation
por: Miller, Robert J H, et al.
Publicado: (2016)

Essential components in natriuretic peptide-guided management of heart failure: an intervention synthesis
por: Oke, Jason, et al.
Publicado: (2018)

Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
por: Wolodimeroff, Elena, et al.
Publicado: (2022)

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team
por: Masters, Jayne, et al.
Publicado: (2017)

Body mass index and survival in people with heart failure
por: Jones, Nicholas R, et al.
Publicado: (2023)

Characterisation of the patients with suspected heart failure: experience from the SHEAF registry
por: Garg, Pankaj, et al.
Publicado: (2021)

Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study
por: Chow, V, et al.
Publicado: (2014)

Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004–2018
por: Taylor, Clare J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_coeehjtv5s049td2mvmf5i54ab